MedTrace Logo

Turkish Version of The Conceptualization of Pain Questionnaire

NCT05436353 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2024-02-14

No results posted yet for this study

Summary

The Conceptualization of Pain Questionnaire (COPAQ), has been presented to the literature in order to evaluate the concept of pain in children and its psychometric properties. This scale, which was developed by Salvat et al., is stated as a tool that consists of a total of 15 items and is easy to administer and respond to. The total score is calculated with the correct or incorrect answers given by the children to these items, and the higher this score, the better the child's understanding of the concept of pain. Moreover; it has been shown that the scale has good fit and internal consistency. In Turkey, there is no valid and reliable scale to evaluate the concept of pain in a child with chronic pain.

The aim of this study is to create the Turkish version of "The Conceptualization of Pain Questionnaire (COPAQ)", which evaluates the concept of pain in children with chronic pain, and to question the Turkish validity and reliability of this scale.

Conditions

Interventions

OTHER

Turkish validity and reliability

Contact with developers and formation of steering committee Translation from English to Turkish Back translation from Turkish to English Comparison of translation Review of translated versions. Reaching consensus and development of pilot version Testing in clinical setting Revision of pilot version Testing of final version

Sponsors & Collaborators

  • Pamukkale University

    collaborator OTHER

  • Kutahya Health Sciences University

    lead OTHER

Principal Investigators

  • Bilge Başakçı ÇALIK, Prof. · Pamukkale University

Eligibility

Min Age
7 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-04
Primary Completion
2023-05-15
Completion
2024-02-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05436353 on ClinicalTrials.gov